Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 4/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | LCK | P06239 | 1/20 | 0.56 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
| ▸ | AKR1C3 | P42330 | 5/20 | 0.53 |
| ▸ | AKR1C2 | P52895 | 5/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29853731 | 0.87 | KDM4E (0.61) | SMN1; SMN2POLBKDM4ELCKFYN | |
| SCHEMBL23457081 | 0.86 | RAB9A (0.58) | SMN1; SMN2POLBKDM4EHPGDALDH1A1 | |
| SCHEMBL31682610 | 0.86 | RAB9A (0.58) | SMN1; SMN2POLBKDM4EHPGDALDH1A1 | |
| SCHEMBL1180221 | 0.86 | LCK (0.58) | SMN1; SMN2POLBKDM4ELCKFYN | |
| SCHEMBL1652968 | 0.85 | ALDH1A1 (0.59) | SMN1; SMN2POLBKDM4EHPGDALDH1A1 | |
| SCHEMBL385581 | 0.83 | KMT2A (0.60) | POLBKDM4EHPGDALDH1A1KMT2A | |
| SCHEMBL227584 | 0.83 | HPGD (0.52) | SMN1; SMN2POLBKDM4EHPGDALDH1A1 | |
| SCHEMBL3341574 | 0.83 | HPGD (0.52) | SMN1; SMN2POLBKDM4EHPGDALDH1A1 | |
| SCHEMBL503802 | 0.82 | POLB (0.70) | SMN1; SMN2POLBKDM4ELCKFYN | |
| SCHEMBL383820 | 0.82 | ALDH1A1 (0.66) | SMN1; SMN2POLBKDM4EHPGDAKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-119285635-A | Synthesis of 8H-indolo [3,2,1-DE ] phenanthridine-8-ketone compound from carbazole and o-bromobenzoic acid and synthesis method thereof | 陕西科技大学 | 2025-01-10 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-107674068-B | Method for synthesizing chlorantraniliprole derivative intermediate | 浙江工业大学 | 2023-12-19 | — | — | CN | claimed |
| CN-116715649-A | Liver cancer medicine four carbon chain cyclohexylimine methyl urolithin A and its preparation method and application | 武汉大学人民医院（湖北省人民医院） | 2023-09-08 | — | — | CN | claimed |
| CN-116549441-A | Anti-aging composition containing urolithin A and 7, 8-dihydroxyflavone, and preparation method and application thereof | 苏州麦轮生物科技有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-116478093-A | Molecular probe for targeting interferon gene stimulus factor, labeling method and application | 厦门大学 | 2023-07-25 | — | — | CN | claimed |
| CN-116396159-A | Synthesis method of 2,2' -biphenyl dicarboxylic acid compound | 湖南大学 | 2023-07-07 | — | — | CN | claimed |
| CN-115974678-A | Synthesis process of 2-bromo-5-methoxybenzoic acid | 浙江司太立制药股份有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-115819732-A | Active polymerization cyclic palladium catalyst and preparation method and application thereof | 合肥工业大学 | 2023-03-21 | — | — | CN | claimed |
| WO-2008079225-A1 | PROCESS FOR THE SYNTHESIS OF ETHERS OF AROMATIC ACIDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-07-03 | — | — | WO | claimed |
| WO-2008079218-A1 | PROCESS FOR THE SYNTHESIS OF ETHERS OF AROMATIC ACIDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-07-03 | — | — | WO | claimed |
| US-7311767-B2 | Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens | XEROX CORPORATION (US) | 2007-12-25 | — | — | US | claimed |
| US-7033424-B2 | Phase change inks | XEROX CORPORATION (US) | 2006-04-25 | — | — | US | claimed |
| US-20060021546-A1 | Processes for preparing phase change inks | XEROX CORPORATION | 2006-02-02 | — | — | US | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060016369-A1 | PHASE CHANGE INKS | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| WO-2005075471-A2 | THIAZOL-COMPOUNDS AS 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITORS | BIOVITRUM AB (SE) | 2005-08-18 | — | — | WO | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | SMN1; SMN2 4149/4885POLB 1788/4885KDM4E 1814/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | SMN1; SMN2 3422/4885POLB 1132/4885KDM4E 1567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.